Term
| degenerative disease of the CNS primarily affecting the white matter; damages the myelin sheath and eventually scars neuronal axons |
|
Definition
|
|
Term
| t/f: multiple sclersis most common in women 20-50 years old |
|
Definition
|
|
Term
| t/f: multiple sclerosis occurs most commonly in temperate climates |
|
Definition
|
|
Term
| risk factors that may trigger the onset of multiple sclerosis |
|
Definition
| genetics and environment (viruses, trauma, and exposure to heavy metals) |
|
|
Term
| 4 disease types of multiple sclerosis |
|
Definition
| relapsing-remitting, primary progressive, secondary progressive, and progressive relapsing |
|
|
Term
| relapsing/remitting disease |
|
Definition
| 65% of cases relapse, develop over 1-2 weeks, resolve over 4-8 weeks, and return to baseline |
|
|
Term
| relapsing/progressive disease |
|
Definition
| 15% of cases are similar to the relapsing/remitting form but with less recovery (the baseline is NOT returned to), and the individual is left with significant residual disability |
|
|
Term
| Chronic progressive disease |
|
Definition
| 20% of cases are characterized by spinal cord and cerebellar dysfunction; symptoms of the spinal cord and cerebellum are the initial manifestations |
|
|
Term
|
Definition
| used for individuals who have had no active clinical disease or any subjective deterioration in their condition during the last year |
|
|
Term
| t/f: MS etiology is unknown, but AIDs is suspected |
|
Definition
|
|
Term
| demyelinating disease in which axonal myelin in the CNS is eroded, destroyed and replaced by scar tissue. it is caused by genetic and environmental factors which causes inflammation of venules in the CNS which disrupts the blood-brain barrier, allowing lymphocytes to enter the CNS tissue, the lymphocytes proliferate nd produce and antibody that attacks and damages myelin and causes the release of the inflammatory chemicals and edema. |
|
Definition
| (Acute Attack) Multiple Sclerosis |
|
|
Term
|
Definition
| antibody produced by lymphocytes that cross the blood-brain barrier in MS that attacks and damages myelin and causes the release of inflammatory chemicals and edema |
|
|
Term
| t/f: as inflammation subsides, the myelin regenerates and manifestations of the disease (MS) subside |
|
Definition
|
|
Term
| patches destroyed along the axon of myelin sheath |
|
Definition
|
|
Term
| t/f: demyelination slows conduction of nerve impulses and sometimes results in total absence of transmission |
|
Definition
|
|
Term
| t/f: demyelination requires more energy to conduct an impulses (200x more) |
|
Definition
|
|
Term
|
Definition
| Brain and Spinal cord (scarring) |
|
|
Term
| t/f: fatigue is a common symptom of MS |
|
Definition
|
|
Term
| after repeated inflammatory attacks, myelin is irreparably damaged; segments of axons become totally demyelinated and may degenerate. |
|
Definition
|
|
Term
| when astrocytes proliferate in damaged regions of CNS and form plaques that are scattered, appearing as gray or pinkish lesions |
|
Definition
|
|
Term
| t/f: in an undamaged neuron, impulses travel down the axon by "leaping" from one node of Ranvier to the next, thus greatly increasing the speed of impulse transmission |
|
Definition
|
|
Term
| what happens when a nerve impulse travels down an axon damaged by MS? |
|
Definition
| the impulses are significantly slowed and weakened as they cross the surface of demyelinated areas; they may be blocked entirely when axons degenerate. |
|
|
Term
| t/f: the weakening or interruption of the transmission of nerve impulses and plaque formation within the CNS cause the manifestations of MS, including extremity weakness, paresthesias, visual disturbances, bladder dysfunction, and vertigo |
|
Definition
|
|
Term
| 4 categories of S&S of MS |
|
Definition
| sensory, motor, cerebellar, and misc. |
|
|
Term
| numbness, burning, prickling, tingling, pain |
|
Definition
|
|
Term
| decreased sense of temperature, depth, and vibration |
|
Definition
|
|
Term
| Uncoordinated movement is due to a muscle control problem that causes an inability to coordinate movements. It leads to a jerky, unsteady, to-and-fro motion of the middle of the body (trunk) and an unsteady gait (walking style). It can also affect the limbs. |
|
Definition
|
|
Term
| Nystagmus is a term to describe fast, uncontrollable movements of the eyes that may be: Side to side (horizontal nystagmus); Up and down (vertical nystagmus); Rotary (rotary or torsional nystagmus). Depending on the cause, these movements may be in both eyes or in just one eye |
|
Definition
|
|
Term
|
Definition
|
|
Term
| the worsening of neurologic symptoms in multiple sclerosis (MS) and other neurological, demyelinating conditions when the body gets overheated from hot weather, exercise, fever, or saunas and hot tubs. It is possibly due to the effect of increased temperature on nerve conduction. With an increased body temperature, nerve impulses are either blocked or slowed down in a damaged nerve but once the body temperature is normalized, signs and symptoms may disappear or improve. |
|
Definition
|
|
Term
| the barber chair phenomenon, is an electrical sensation that runs down the back and into the limbs. In many patients, it is elicited by bending the head forward. It can also be evoked when a practitioner pounds on the posterior cervical spine while the neck is flexed; this is caused by involvement of the posterior columns |
|
Definition
|
|
Term
|
Definition
|
|
Term
| when you have difficulty saying words because of problems with the muscles that help you talk. |
|
Definition
|
|
Term
| t/f: MS is difficult to diagnose because there is no definitive test |
|
Definition
|
|
Term
| t/f: MS diagnosis made on clinical history, presentation of symptoms, and the elimination of other neurologic deficits |
|
Definition
|
|
Term
| t/f: MS treatment is aimed at treating acute attacks, and decreasing the number of attacks and subsequent neurologic disabilities |
|
Definition
|
|
Term
|
Definition
| corticosteroids, interferon, and Imuran |
|
|
Term
| t/f: with parkinson's and ms, focus care on preventing injuries and complications. safety is a major concern with these patients. |
|
Definition
|
|
Term
| t/f: in MS, there are meds available to cure disease |
|
Definition
FALSE!
NO CURE! meds only treat symptoms |
|
|
Term
| Immunomodulating Agents for MS |
|
Definition
Interferon beta- 1a (Avonex; Rebif)- Glatiramer Copaxone)
Interferon beta- 1b (Betaseron - Natalizumab- Tysabri) |
|
|
Term
| Immunosuppressive Agents for MS |
|
Definition
|
|
Term
| Antiinflamatory Agents for MS |
|
Definition
|
|
Term
|
Definition
| baclofen (Lioresal); Dantrium; Valium |
|
|
Term
| Anticholinergics/Cholinergics for MS |
|
Definition
|
|
Term
| plasma exchange procedure that removes the plasma component from whole blood. |
|
Definition
|
|
Term
| what is the goal of plasmapheresis? |
|
Definition
| to remove inflammatory agents, such as T Lymphocytes |
|
|
Term
| t/f: plasmapheresis is very similar to hemodialysis because it is also accessed through an artery and vein where blood passes through a blood separater where the plasma is removed, and then cellular blood components are re-transfused using fresh-frozen plasma or albumin |
|
Definition
|
|
Term
| how is foot drop relieved? |
|
Definition
|
|
Term
| progressive, degenerative neurologic disease characterized by non-intention tremor, bradykinesia, muscle rigidity, and postural instability |
|
Definition
|
|
Term
| t/f: Parkinson's is most common among males over 50 years old |
|
Definition
|
|
Term
| t/f: Parkinson's is the 2nd most common neurodegenerative disorder |
|
Definition
|
|
Term
| t/f: Parkinson's etiology is unknown |
|
Definition
|
|
Term
| commonly occuring, slowly progressive, degenerative disorder caused by dopamine deficiency |
|
Definition
|
|
Term
|
Definition
| it carries messages to tell the body how and when to move |
|
|
Term
| t/f: shortage of dopamine causes movements to become more difficult |
|
Definition
|
|
Term
| t/f: Secondary parkinsonism is similar to Parkinson's disease, but it is caused by certain medicines, a different nervous system disorder, or another illness. |
|
Definition
|
|
Term
| what is the most distinct tremor of parkinsons? (non-intention tremor) |
|
Definition
| "pill-rolling" of thumb and forefinger |
|
|
Term
| t/f: stress and anxiety increase all tremors |
|
Definition
|
|
Term
|
Definition
| normal balance between excitatory and inhibitory neurotransmitters is disrupted; disorder of voluntary motor function occurs |
|
|
Term
| neurotransmitter involved in motor function |
|
Definition
|
|
Term
| why is the dopamine level affected? |
|
Definition
| atrophy of neurons of the substantia nigra |
|
|
Term
| which neurons produce dopamine |
|
Definition
| neurons of the substantia nigra |
|
|
Term
| difficulty in initiating a movement, then moving very slowly (frozen in place) |
|
Definition
|
|
Term
| involuntary, short, rapid, shuffling |
|
Definition
|
|
Term
|
Definition
|
|
Term
| itchy rash, white scaley skin |
|
Definition
|
|
Term
| cardinal signs of parkinsons disease |
|
Definition
1. resting tremors and shaking
2. muscle rigidity and stiffness
3. bradykinesia
4. postural instability |
|
|
Term
| how is parkinson's disease diagnosed? |
|
Definition
| complete health assessment, medical history, and complete neurologic examination |
|
|
Term
| t/f: parkinson's disease cannot be cured or arrested but symptoms can be controlled with drug therapy |
|
Definition
|
|
Term
| drugs used to decrease akinesia in parkinson's patients |
|
Definition
| Levodopa, dopamine agonists, anticholinergic drugs, antihistamines, and amantadine |
|
|
Term
| t/f: parkinson's drugs are not initiated until the symptoms become incapacitating because of the side effects and a decreased responsiveness after 5 years |
|
Definition
|
|
Term
| t/f: treatment with levodopa does not prevent the progressive changes that are typicl of Parkinson's disease |
|
Definition
|
|
Term
| eyes become fixed with a lateral and upward gaze |
|
Definition
|
|
Term
| t/f: there is no test for Parkinson's disease |
|
Definition
|
|
Term
| t/f: PD pharm. goal is to control symptoms to greatest extent possible |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| apomorphine; bromocriptine; parmipexole; ropinirole; rotigotine transdermal system |
|
|
Term
| monoamine oxidase B inhibitors for PD |
|
Definition
| selegiline/deprenyl; rasagiline |
|
|
Term
| catecholOmethyltransferase inhibitors for PD |
|
Definition
|
|
Term
|
Definition
| trihexyphenidyl; benztropine, ethopropazine |
|
|
Term
| glutamate antagonist for PD |
|
Definition
|
|
Term
| surgical treatment involving the implantation of a medical device called a brain pacemaker, which sends electrical impulses to specific parts of the brain; In select brain regions it has provided therapeutic benefits for otherwise-treatment-resistant movement and affective disorders such as Parkinson's disease, essential tremor, dystonia, and chronic pain |
|
Definition
|
|
Term
| recent development; locates affected area(s) in the brain and destroys involved tissue |
|
Definition
|
|
Term
| destroys small amount of tissue in thalamus with needle; used to decrease tremors and rigidity |
|
Definition
|
|
Term
| adrenal medullary grafted to basal ganglia |
|
Definition
| autologous adrenal medullary transplant |
|
|
Term
|
Definition
| difficulty with motor control of the mouth |
|
|
Term
agnosia
ataxia
aphraxia
aphasia |
|
Definition
|
|
Term
|
Definition
shakes at rest but usually stop when reaching for something
Parkinsons |
|
|
Term
|
Definition
| fine at rest but shakes when reaching for something; MS |
|
|
Term
| Famous people with Parkinson's |
|
Definition
| Hitler, Michael Fox, Muhammed Ali |
|
|
Term
| (PARKINSONS or HUNTINGTONS) Increase in acetecholine, decrease in dopamine |
|
Definition
|
|
Term
| (PARKINSONS or HUNTINGTONS) Decrease in acetecholine, increase in dopamine |
|
Definition
|
|
Term
| why do parkinson's patients have night mares? |
|
Definition
| anti-dyskinetics produce nightmares and hallucinations |
|
|
Term
|
Definition
| crosses blood brain barrier and converts to dopamine |
|
|
Term
|
Definition
| protects dopamine and holds it in |
|
|
Term
| carbidopa and levodopa mixed together |
|
Definition
|
|
Term
|
Definition
| a substance that fully activates the neuronal receptor that it attaches to |
|
|
Term
|
Definition
| a substance that attaches to a receptor but does not activate it or if it displaces an agonist at that receptor it seemingly deactivates it thereby reversing the effect of the agonist |
|
|
Term
|
Definition
| a separation of the circulating blood from the brain extracellular fluid (BECF) in the central nervous system |
|
|
Term
| progressive, degenerative, inherited neurologic disease characterized by increasing dementia and chorea; single-gene autosomal-dominant inherited disease that affects the neurons of the basal ganglia |
|
Definition
|
|
Term
| jerky, rapid, involuntary movements; dancing or writhin of the limbs or facial muscles |
|
Definition
|
|
Term
| why is huntinginton's also known as "Huntington's Chorea? |
|
Definition
| because chorea is the most common presenting symptom of huntingtons |
|
|
Term
| t/f: huntingtons has a cure |
|
Definition
|
|
Term
| why does dopamine increase in huntingtons? |
|
Definition
| Gamma-aminobutyric acid (GABA) is decreased and acetylcholine is decreased, which results in an excess of dopamine |
|
|
Term
| autosomal dominant disorder means |
|
Definition
| if you have the gene, you have the disorder |
|
|
Term
| excess of dopamine contributes to these s&s of huntingtons |
|
Definition
| severe depression, memory loss with decreased ability to concetrate, emotional lability, impulsiveness, mood swings, dementia, disorientation, confusion |
|
|
Term
| t/f: in huntingtons, motor signs worsen with environmental stimuli and emotional stress |
|
Definition
|
|
Term
| t/f: in huntingtons, motor signs usually are absent when sleeping |
|
Definition
|
|
Term
| t/f: in huntingtons, death is usually caused by aspiration pneumonia or another infection |
|
Definition
|
|
Term
| how to diagnose huntingtons |
|
Definition
| genetic testing (chromosome 4) |
|
|
Term
| pharmacology for huntingtons |
|
Definition
| antipsychotics; block dopamine; antidepressants |
|
|
Term
| huntingtons: t/f: death usually occurs within a year after being diagnosed |
|
Definition
|
|
Term
| early symptoms of huntingtons: |
|
Definition
| mood swings, depression, irritbility, trouble driving, learning new things, remembering facts or making decisions; abnormal movement and pregressive dysfunction of intellectual and thought processes |
|
|
Term
|
Definition
|
|
Term
| a heightened state of well-being |
|
Definition
|
|
Term
| t/f: each child of an HD parent has a 50% chance of inheriting the HD gene. Anyone who inherits the gene will eventually develop the disease |
|
Definition
|
|
Term
| t/f: dopamine agonist drugs cn help control the movement disorder of HD |
|
Definition
|
|
Term
| progressive, degenerative neurologic disease characterized by weakness and wasting of involved muscles WITHOUT sensory or cognitive changes; disease of the upper and lower motor neurons; leads to respiratory failure; has two names |
|
Definition
| Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease |
|
|
Term
| what differentiates Lou Gehrig's (ALS) from other motor neuron disorders? |
|
Definition
1. involvement of both the upper and lower motor neurons
2. the degeneration is not accompanied by inflammation |
|
|
Term
| t/f: lou gehrig's disease slightly higher possibility in men |
|
Definition
|
|
Term
| most common motor neuron disease |
|
Definition
|
|
Term
|
Definition
| without muscle nutrition; progressive muscle wasting |
|
|
Term
| lateral sclerosis refers to: |
|
Definition
| the scarring that takes place in the lateral column of the spinal cord, which is the upper motor neuron component of the ALS lou gehrigs syndrome |
|
|
Term
| defined as overactive or overresponsive reflexes. Examples of this can include twitching or spastic tendencies, which are indicative of upper motor neuron disease as well as the lessening or loss of control ordinarily exerted by higher brain centers of lower neural pathways (disinhibition) |
|
Definition
|
|
Term
| involuntary contraction or twitching of muscle fibers |
|
Definition
|
|
Term
|
Definition
| muscle spasticity, hyperreflexia, faciculations, tongue atrophy, dysarthria, fatigue, urinary and bowel dysfunctions |
|
|
Term
| t/f: in ALS Lou Gehrig's Disease, intellectual ability, sensory function, vision, and hearing are all affected |
|
Definition
| FALSE! NONE ARE AFFECTED! |
|
|
Term
| T/F: cpk (creatinine phosphokinase) may be elevated in ALS |
|
Definition
|
|
Term
|
Definition
| antiglutamate that slows deterioration in ALS |
|
|
Term
| t/f: Lou Gehrigs patients are at risk for aspiration and pneumonia |
|
Definition
|
|
Term
| chronic, progressive neuromuscular disorder characterized by fatigue and severe weakness of the skeletal muscles; experiences remissions and exacerbations |
|
Definition
|
|
Term
| t/f: MG occurs more in women than in men |
|
Definition
|
|
Term
|
Definition
| antibodies destroy/block neuromuscular junction receptor sites, resulting in decrease in number of acetylcholine receptors; also structural changes that result in diminished acetylcholine uptake; results in Decrease in muscle's ability to contract; (weakness and rapid fatigue) |
|
|
Term
| why do MG patients have to have thymectomys? |
|
Definition
| the thymus gland never disappears when they mature and becomes a tumor which is believed to be source of the auto-antigens |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| t/f: MG symptoms increase with repeated activity and improve with rest, so its best to do things in the morning before the fatigue sets in |
|
Definition
|
|
Term
|
Definition
| DYSARTHRIA, DYSPHAGIA, PTOSIS, DIPLOPIA, NASAL SOUND TO VOICE, AND WEAK NECK MUSCLES |
|
|
Term
|
Definition
| sudden exacerbation of motor weakness; often due to under medication, missed doses, or developing infection; insufficiency of acetylcholine ; life threatening |
|
|
Term
|
Definition
| tachycardia, tachypnea, severe respiratory distress, dyspagia, restlessness, impaired speech, anxiety |
|
|
Term
|
Definition
| result of over-dosage of medication; excess of acetylcholine |
|
|
Term
|
Definition
| gi symptoms, severe muscle weakness, vertigo, respiratory distress |
|
|
Term
| how are myasthenic and cholinergic crisises differentiated? |
|
Definition
|
|
Term
|
Definition
| edrophonium chloride is given IV and individual is observed for muscle tone improvement. |
|
|
Term
| t/f: in tensilon test, muscle improvement is myasthenic crisis |
|
Definition
|
|
Term
| t/f: in tensilon test, if there is no improvement in muscle tone, test is negative and crisis is cholinergic |
|
Definition
|
|
Term
|
Definition
| because S&S are very similar |
|
|
Term
|
Definition
1. anticholinesterases: allow acetylchoine to concentrate at receptor sites: Mestinon- most common, prolongs contraction of muscles
2. corticosteroids- suppress antibodies that block Ach-R (Prednisone)
3. Immunosuppressants: used when other meds fail to reduce symptoms |
|
|
Term
| the complete exchange of plasma |
|
Definition
|
|
Term
| acute inflammatory demyelinating disorder of the PNS; progressive, usually with rapid muscle weakness and paralysis; one of the most common PNS disorders; usually occurs after a viral respiratory or GI infection |
|
Definition
|
|
Term
| t/f: GBS rehabilitation time varies from 6 months to 2 years |
|
Definition
|
|
Term
| t/f: GBS usually ascending |
|
Definition
|
|
Term
|
Definition
| muscle weakness starts in legs and works its way up to arms and trunk |
|
|
Term
|
Definition
| muscle weakness starts in the arms and works its way down to the legs |
|
|
Term
|
Definition
| the symptoms begin in the patient's head. The illness affects eye muscles and balance first. It then slowly moves down the body to the neck, arms and other areas. |
|
|
Term
| acute panautonomic neuropathy |
|
Definition
| affects ALL the nerves, CNS and PNS |
|
|
Term
| t/f: GBS initially in lower extremeties, then to upper extremeties, torso, and cranial nerves |
|
Definition
|
|
Term
|
Definition
|
|
Term
| what do you do to GBS patients who can't close their eyes? |
|
Definition
Eye Drops
Eye creams
Tape Eyes shut |
|
|
Term
|
Definition
|
|
Term
| t/f: 85% of GBS patients recover completely |
|
Definition
|
|
Term
| chronic disease of the trigeminal cranial nerve that causes severe facial pain |
|
Definition
| trigeminal neuralgia (tic douloureux) |
|
|
Term
| contributing factors to trigeminal neuralgia |
|
Definition
- irritation from flu
- trauma or infection of teeth or jaw
- pressure on nerve by aneurysm
- tumor
- arteriosclerotic changes of artery near nerve |
|
|
Term
| t/f: Tic douloureux can be characterized by brief repetitive episodes of sudden severe facial pain that may occur as often as hundreds of times per day to as infrequently as a few times a year |
|
Definition
|
|
Term
| how is the trigeminal neuralgia pain described? |
|
Definition
| stabbing or lightning-like pain |
|
|
Term
| t/f: trigeminal neuralgia can be irritated by eating, light touch, talking, swallowing, brushing teeth, shaving, etc. |
|
Definition
|
|
Term
|
Definition
| surgical severing of a nerve root |
|
|
Term
|
Definition
| closed procedure where needle goes through cheek into foramen ovale at the base of the brain to partially destroy trigeminal nerve |
|
|
Term
|
Definition
| total severing of nerve root |
|
|
Term
| disorder of the facial nerve; characterized by unilateral paralysis of facial muscles; the eye does not close and the forehead does not wrinkle; impairs taste; individual cannot smile, whistle or grimace; paralyzed side is masklike and sags with constant tearing of the eye and possible drooling |
|
Definition
|
|
Term
| t/f: bells palsy has a relationship to herpes simplex virus |
|
Definition
| true (uh oh Jenny ;) LOL) |
|
|
Term
| t/f: decompression of facial nerve cures bell's palsy |
|
Definition
| FALSE! no evidence that doing so is of value |
|
|
Term
| viral infection of CNS transmitted by infected saliva that enters through open wound; frequently causes death; virus carried by wild and domestic animals |
|
Definition
|
|
Term
| pathophysiology of rabies |
|
Definition
| spreds from wound to local muscle cells and then invades peripherl nerves; eventually travels to CNS |
|
|
Term
|
Definition
|
|
Term
|
Definition
| site is painful; exhebits various paresthesias, anxiety, irritability, depression |
|
|
Term
|
Definition
| periods of excitement and quiet; hydrophobia; thick mucus; convulsions, muscle spasms, periods of apnea, death can occur in 7 days (The Ring? SEVEN DAYS) |
|
|
Term
| disorder of the nervous system caused by a neurotoxin from clostridium tetni; anaerobic bacillus lives in the soil; spres enter body through open wound, germinate, and produce the tetanospasmin toxin |
|
Definition
|
|
Term
|
Definition
| stiffness, dysphagi, profuse perspiration, hyperreflexia, jaw/neck/facial muscle spasms, tonic seizures |
|
|
Term
|
Definition
|
|
Term
| what toxin produces botulism? |
|
Definition
| clostridium botulinum; found in soil; most cases from eating improperly canned or cooked foods |
|
|
Term
| pathophysiology of botulism |
|
Definition
| toxins absorbed by GI tract and bind to nerve tissues; block release of acetylcholine from nerve endings |
|
|
Term
| complication of previous infection by poliomyelitis virus; increased in women; |
|
Definition
|
|
Term
| pathophysiology of post-polio syndrome |
|
Definition
| virus destroys some of the motor cells of the anterior horn of the spinal cord; mild to severe flaccid paralysis and atrophy; signs emerge years after initial infection; seen in those who had a severe case of polio with hospitalization |
|
|
Term
| a cluster of symptoms localized near the jaw; can be caused by degenerative arthritis of mandibular joint, teeth malocclusion, bruxism, dislocation of jaw during ET; occurs when the meniscus, cartilaginous disk, between condyle and temporal bone dislaced; results in s&S |
|
Definition
| Temporomandibular Disorder (TMD) (TMJ) |
|
|
Term
|
Definition
| jaw pain, HA, tinnitus, ear pain, clicking of jaw, may even lock periodically |
|
|
Term
| neurologic disorder characterized by persistent tics |
|
Definition
|
|
Term
| sudden involuntary movements and vocalizations |
|
Definition
|
|
Term
| t/f: no two tourettes patients are the same |
|
Definition
|
|
Term
| t/f: tourretes does not impair intelligence |
|
Definition
|
|
Term
| neurological disorder characterized by paresthesias or dysethesias of legs |
|
Definition
|
|
Term
| t/f: in RLS, leg pain eases with motion of legs nd is more noticeable at rest |
|
Definition
|
|
Term
| comes from the Greek words meaning "not-normal" and "sensation" (abnormal sensation)It is defined as an unpleasant, abnormal sense of touch. It often presents as pain but may also present as an inappropriate, but not discomforting, sensation. It is caused by lesions of the nervous system, peripheral or central, and it involves sensations, whether spontaneous or evoked, such as burning, wetness, itching, electric shock, and pins and needles |
|
Definition
|
|
Term
| the excessive grinding of the teeth and/or excessive clenching of the jaw |
|
Definition
|
|
Term
| any disease of the nerves |
|
Definition
|
|
Term
| any syndrome causing muscle weakness, paresthesias, impaired reflexes, and autonomic symptoms in the hands and feet |
|
Definition
| peripheral neuropathy (polyneuritis, polyneuropathy) |
|
|
Term
| t/f: diabetes mellitus is the most common cause of metabolic neuropathy |
|
Definition
|
|
Term
| t/f: alcoholism is the most common nutrition related neuropathy |
|
Definition
|
|
Term
| group of genetic disorders that affects the cell growth of neural tissues; has two names and two types; can very from skin spots to tumors, scoliosis, seizures, gliomas, neuromas, htn, and mental retardation |
|
Definition
| neurofibromatosis (von recklinghausen's disease) |
|
|
Term
| type one neurofibromatosis |
|
Definition
| skin spots, non/malignant neurofibromas, scoliosis, seizures, gliomas, neuromas, htn, and mental retardation; no cure |
|
|
Term
| type two neurofibromatosis |
|
Definition
| intracranial and spinal tumors; 8th cranial nerve is especilly susceptible; palliative care |
|
|
Term
| t/f: glossopharyngeal neuralgia is similar to trigeminal neuralgia but is more rare |
|
Definition
|
|
Term
| difference between glossopharyngeal and trigeminal neuralgia |
|
Definition
| glossopharyngeal orginates in throat and cn affect ear; trigeminal is facial pain. |
|
|
Term
| intense, sudden, and repeating pain |
|
Definition
|
|
Term
| syndrome caused by continuous signaling of the end regions of peripheral nerve fibers that activate muscle fibers; causes muscle stiffness, continuous twitching/vibrating of muscles, cramping, increased sweating, and delayed muscle relaxation; has three names |
|
Definition
| Isaac's syndrome (neuromyotonia, continuous muscle fiber activity syndrome) |
|
|
Term
| t/f: symptoms of Isaac's syndrome cn occur even during sleep or when under general anesthesia |
|
Definition
|
|
Term
| t/f: when confusion, hallucinations, and insomnia are associated with Isaac's syndrome, the condition is known as Marfan's syndrome |
|
Definition
|
|
Term
| progressive loss of cognitive and intellectual functions without impairment of perception or consciusness |
|
Definition
|
|
Term
| the onset of delirium during the evening or night with disappearance of delirium during the day |
|
Definition
|
|
Term
| chronic neurologic disorder that involves progressive and selective degeneration of neurons in the cerebral cortex and certain subcortical structures; most common in women; loses ability to perform ADLs, impairment of short/long term memory, aphasic, apraxic, complete loss of cognitive function and emotional response |
|
Definition
|
|
